Clinical Study
A High Dose Intravenous Immunoglobulin Therapy for Women with Four or More Recurrent Spontaneous Abortions
Table 2
Patient characteristics and the comparison between live birth and spontaneous abortion groups.
| | Age (year-old) | Number of previous abortions | Percentage of primary RSA | Gestational week of immunoglobulin injection | Gestational week of delivery or abortion | Birth weight (g) |
| | Total | | 35 (23–44) | 4.5 (4–8) | 85.0% | 5 (4–7) | | |
| | Outcome | | Live birth | | 34.5 (23–42) | 4 (4–8) | 84.1% | 5 (4–7) | 38 (29–41) | 2815 (636–3570) |
| | Spontaneous abortion | | 37 (27–44)* | 5 (4–8) | 86.7% | 5 (4–6) | 8 (6–9) | — |
|
|
Median (range).
*
P = 0.067 compared with age of live birth group.
RSA: recurrent spontaneous abortion.
|
